Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1068 of 5804
-
New adaptive radiation trial aims to cut prostate cancer treatment time without sacrificing quality of life
Disease control Recruiting nowIn this prospective, multi-center cohort study, the tolerability and quality of life during ultrahypofractionated radiotherapy (RT) of early stage prostate cancer is surveyed at several institutions in Germany. Radiotherapy is delivered by an online-adaptive RT device (Varian Eth…
Sponsor: Jena University Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can urine sodium levels guide better heart failure treatment?
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if increasing the dose of diuretics to achieve a higher urine sodium target produces better clinical results when treating patients hospitalized with acute heart failure when compared to lower urine sodium target and standard of care. …
Phase: PHASE4 • Sponsor: Lakeland Regional Health Systems, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
New eye drug faricimab aims to control wet AMD with fewer shots
Disease control Not yet recruitingIf the subject who has nAMD voluntarily agrees to participate in this clinical study by signing the informed consent form, screening assessments will be conducted within 4 weeks prior to the first dose of the investigational drug. During the screening visit, the eligibility of th…
Phase: PHASE4 • Sponsor: Junyeop Lee • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug aims to tame dangerous blood fats
Disease control Recruiting nowThe purpose of the study is to evaluate the efficacy and safety of SHR-1918 in patients with hypertriglyceridemia. The efficacy and safety of SHR-1918 will be evaluated after 24-weeks and 48-weeks treatment.
Phase: PHASE3 • Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug cocktail takes on advanced liver cancer
Disease control Not yet recruitingThis is an open-label, multicenter, Phase I/II clinical study designed to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of MRG006A in combination with immune checkpoint inhibitors and targeted therapy in patients with advanced hepatocellular carcin…
Phase: PHASE1, PHASE2 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Pre-Surgery workouts may boost recovery in lung cancer
Symptom relief Not yet recruitingThe PREHAB study focuses on patients with locally advanced non-small cell lung cancer (NSCLC) undergoing neoadjuvant chemotherapy and/or immunotherapy prior to surgical resection. These systemic treatments frequently impair patients' physiological reserve, reduce physical fitness…
Phase: NA • Sponsor: Hôpital du Valais • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Extra radiation boost may help control spine tumors and ease pain
Disease control Recruiting nowSpine SBRT is considered a standard of care for the treatment of spinal metastases. Compared to conventional radiation therapy, spine SBRT delivers high doses of radiation to the affected areas to the spinal metastases. This study is interested in seeing whether an additional 'b…
Phase: PHASE2 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Can a fungus slow ALS? new trial targets high sphingolipids
Disease control Not yet recruitingAmyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by the degeneration of motor neurons, leading to progressive muscle weakness and functional decline. This study is designed as a randomized, double-blind, placebo-controlled clinical tria…
Phase: PHASE2 • Sponsor: The Third Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New shorter radiation regimen aims to cut treatment time for head and neck cancer patients
Disease control Not yet recruitingThis study aims to evaluate the safety and efficacy of hypofractionated radiotherapy in patients with postoperative intermediate-risk head and neck squamous cell carcinoma.
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Blood test may predict stomach cancer return after surgery
Knowledge-focused Not yet recruitingThis is a single-center, prospective, exploratory study evaluating the use of dynamic circulating tumor DNA (ctDNA) monitoring in the postoperative adjuvant treatment setting for patients with stage III or stage IVA gastric or gastroesophageal junction adenocarcinoma. After cura…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
New combo aims to tame autoimmune anemia without Long-Term steroids
Disease control Not yet recruitingThis study is a prospective, multicenter, randomized controlled trial. A total of 216 adult patients with newly diagnosed wAIHA were planned to be included and randomly assigned in a 1:1 ratio to the experimental group (glucocorticoid combined with sirolimus) or the control group…
Phase: NA • Sponsor: Chen Miao • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Can starting prehab early boost ovarian cancer outcomes?
Symptom relief Not yet recruitingStandard treatment for advanced ovarian cancer includes a combination of cytotoxic chemotherapy and citorreductive surgery. During neo-adjuvant administration of chemotherapy, many patients experience a decline in their functional capacity, leading to an increased risk of postope…
Phase: NA • Sponsor: Hospital Clinic of Barcelona • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Tailored brain zaps could boost stroke recovery
Symptom relief Not yet recruitingThe goal of this clinical trial is to evaluate the efficacy of a personalized brain stimulation technique, Individual Alpha Frequency (IAF)-based rTMS, for motor function recovery in adult patients with a first-ever ischemic stroke. The main questions it aims to answer are: 1. …
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Blood test breakthrough could speed up fungal lung infection diagnosis
Diagnosis Not yet recruitingThe goal of this clinical trial is to learn whether a blood test called metagenomic next-generation sequencing (mNGS) can help diagnose invasive pulmonary fungal disease in patients with blood disorders. It will also evaluate how accurate this test is compared to traditional meth…
Sponsor: Peking University People's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
New drug aims to cut opioid use after knee surgery
Symptom relief Recruiting nowThis is a prospective, randomized study. The purpose of this study is to evaluate if the addition of Suzetrigine, a new pain medication, to well established peri-operative pain regimen used for total knee replacement surgery will effect pain control. 1. Does Suzetrigine given pr…
Phase: PHASE3 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Bright light therapy may boost brain rehab for veterans with TBI and PTSD
Symptom relief Recruiting nowPosttraumatic stress disorder (PTSD) and mild TBI (mTBI) frequently co-occur in post-9/11 Veterans, and together are associated with worse cognitive performance, mental health, everyday functioning, community integration, quality of life, and treatment response than either condit…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Simple urine test could revolutionize schistosomiasis detection
Diagnosis Not yet recruitingThis study aims to develop and evaluate a nanobody-based urine diagnostic test for Schistosoma haematobium infection through IPSE antigen detection. Approximately 2500 participants will be recruited and divided into five groups: confirmed S. haematobium infection, S. mansoni infe…
Sponsor: Pemba Ministry of Health Zanzibar • Aim: Diagnosis
Last updated Jun 27, 2026 12:03 UTC
-
Blood test could predict chronic GVHD after transplant
Knowledge-focused Not yet recruitingThis study is a single-center observational clinical study. Participants were enrolled as two cohorts of patients including discovery cohort and validation cohort. A total of consecutive 1000 patients receiving allo-HSCT in our center from 2021.01 to 2023.06 were retrospectively …
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
New pacing technique aims to stop irregular heartbeat in heart failure patients
Disease control Not yet recruitingThis is a multi-center, prospective, single-blind, randomized controlled clinical trial to evaluate the efficacy and safety of Bachmann bundle pacing (BBP) in preventing new-onset atrial fibrillation (AF) in patients with chronic cardiac insufficiency who have indications for car…
Phase: NA • Sponsor: Fu Wai Hospital, Beijing, China • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can CBD oil stop migraines before they start? new trial aims to find out
Disease control Recruiting nowThis study will evaluate the efficacy and safety of cannabis for the treatment of chronic migraine headaches. Study subjects will be randomized to one of three groups: lower dose CBD, higher dose CBD or placebo.
Phase: PHASE2 • Sponsor: University of Calgary • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC